Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 2

Clinical challenges in the management of osteoporosis

Authors Sheryl F Vondracek, Paul Minne, Michael T McDermott

Published Date June 2008 Volume 2008:3(2) Pages 315—329

DOI http://dx.doi.org/10.2147/CIA.S2539

Published 30 June 2008

Sheryl F Vondracek1, Paul Minne2, Michael T McDermott3

1Department of Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA; 2Amgen Medical Affairs, Denver, CO, USA; 3Director of the Endocrine and Diabetes Practice, Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO, USA

Abstract: While knowledge regarding the diagnosis and treatment of osteoporosis has expanded dramatically over the last few years, gaps in knowledge still exist with guidance lacking on the appropriate management of several common clinical scenarios. This article uses fictional clinical scenarios to help answer three challenging questions commonly encountered in clinical practice. The first clinical challenge is when to initiate drug therapy in a patient with low bone density. It is estimated that 34 million Americans have low bone density and are at a higher risk for low trauma fractures. Limitations of using bone mineral density alone for drug therapy decisions, absolute risk assessment and evidence for the cost-effectiveness of therapy in this population are presented. The second clinical challenge is the prevention and treatment of vitamin D deficiency. Appropriate definitions for vitamin D insufficiency and deficiency, the populations at risk for low vitamin, potential consequences of low vitamin D, and how to manage a patient with low vitamin D are reviewed. The third clinical challenge is how to manage a patient receiving drug therapy for osteoporosis who has been deemed a potential treatment failure. How to define treatment failure, common causes of treatment failure, and the approach to the management of a patient who is not responding to appropriate osteoporosis therapy are discussed.

Keywords: osteoporosis, osteopenia, bisphosphonate, vitamin D, dual-energy X-ray absorptiometry

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease

Sheryl F Vondracek, Norbert F Voelkel, Michael T McDermott, Connie Valdez

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:267-277

Published Date: 13 July 2009

Readers of this article also read:

SPEEDY babies: A putative new behavioral syndrome of unbalanced motor-speech development

Marja-Leena Haapanen, Tuomo Aro, Elina Isotalo

Neuropsychiatric Disease and Treatment 2008, 4:1225-1233

Published Date: 23 September 2008

Inflammatory mediators: Parallels between cancer biology and stem cell therapy

A Patel, Andrew C Heinrich, Bobby Y Reddy, Pranela Rameshwar

Journal of Inflammation Research 2009, 2:13-19

Published Date: 4 February 2009

Neurotransmitter testing of the urine: a comprehensive analysis

Marty Hinz, Alvin Stein, George Trachte, et al

Research and Reports in Urology 2010, 2:177-183

Published Date: 7 October 2010

Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes

Karen Barnard, Mary Elizabeth Cox, Jennifer B Green

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010, 3:363-372

Published Date: 27 October 2010

Viral vectors for cystic fibrosis gene therapy: What does the future hold?

Uta Griesenbach, Makoto Inoue, Mamoru Hasegawa, et al

Virus Adaptation and Treatment 2010, 2:159-171

Published Date: 13 December 2010

Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays

Yang XQ, Chen C, Peng CW, Hou JX, Liu SP, Qi CB, Gong YP, Zhu XB, Pang DW, Li Y

International Journal of Nanomedicine 2011, 6:2265-2273

Published Date: 11 October 2011

Manufacturing of biodegradable polyurethane scaffolds based on polycaprolactone using a phase separation method: physical properties and in vitro assay

Asefnejad A, Khorasani MT, Behnamghader A, Farsadzadeh B, Bonakdar S

International Journal of Nanomedicine 2011, 6:2375-2384

Published Date: 18 October 2011

Nanofibrous poly(lactide-co-glycolide) membranes loaded with diamond nanoparticles as promising substrates for bone tissue engineering

Parizek M, Douglas TEL, Novotna K, Kromka A, Brady MA, Renzing A, Voss E, Jarosova M, Palatinus L, Tesarek P, Ryparova P, Lisa V, dos Santos AM, Bacakova L

International Journal of Nanomedicine 2012, 7:1931-1951

Published Date: 17 April 2012